| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $420K | — |
| R&D Expense | $19.2M | -5.5% |
| SG&A Expense | $6.7M | -9.0% |
| Operating Income | -$25.5M | +8.0% |
| Pre-tax Income | -$25.6M | +1.4% |
| Income Tax | -$3.0M | +36.5% |
| Net Income | -$22.6M | -6.4% |
| EPS (Diluted) | -$27.24 | -1333.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | -81.6% |
| Current Assets | $7.4M | -69.5% |
| Total Assets | $8.8M | -68.0% |
| Current Liabilities | $8.2M | +10.4% |
| Total Liabilities | $8.2M | +9.3% |
| Stockholders' Equity | $607K | -96.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | +22.6% |
| Capital Expenditures | $6K | -14.3% |
| Investing Cash Flow | -$6K | +14.3% |
| Financing Cash Flow | $848K | -71.7% |
| Free Cash Flow | -$16.1M | +22.6% |